Cargando…

Ex vivo perfusion-based engraftment of genetically engineered cell sensors into transplantable organs

Cellular rejection of liver transplant allografts remains a concern despite immunosuppressant use. Existing transplant biomarkers are often not sensitive enough to detect acute or chronic rejection at an early enough stage to allow successful clinical intervention. We herein developed a cell-based s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Ling-Yee, Carroll, Cailah, Raigani, Siavash, Detelich, Danielle M., Tessier, Shannon N., Wojtkiewicz, Gregory R., Schmidt, Stephen P., Weissleder, Ralph, Yeh, Heidi, Uygun, Korkut, Parekkadan, Biju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886851/
https://www.ncbi.nlm.nih.gov/pubmed/31790444
http://dx.doi.org/10.1371/journal.pone.0225222
Descripción
Sumario:Cellular rejection of liver transplant allografts remains a concern despite immunosuppressant use. Existing transplant biomarkers are often not sensitive enough to detect acute or chronic rejection at an early enough stage to allow successful clinical intervention. We herein developed a cell-based sensor that can potentially be used for monitoring local events following liver transplantation. Utilizing a machine perfusion system as a platform to engraft the cells into a donor liver, we effectively established the biocompatibility of the biosensor cells and confirmed efficient delivery of cells distributed throughout the organ. This work proves an innovative concept of integrating synthetic reporter cells ex vivo into organs as a transplant-within-a-transplant during functional organ preservation with a vision to use cell biosensors as a broad way to monitor and treat tissue transplants.